1M6MYTD1A5AMAX
Chargement des cours...
Prévisions
| Acheter |
5 |
| Conserver |
0 |
| Vendre |
0 |
Actualités Accéder au fil d'actualités
Bio-Path Holdings moves headquarters to Wyoming and creates Series S preferred shares
Bio-Path Holdings approved the move of its headquarters to Wyoming and filed an amendment to its charter to create a new class of Series S preferred shares consisting of 51 shares, each convertible into one common share and representing 1% of diluted voting power. The company also appointed Wendy M. Charles and Michael Hickey to a newly formed scientific advisory board; both received three-year contracts and were granted 100,000 stock options each with an exercise price of $0.06. The information comes from a filing with the SEC. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | juin 2026 | |
|---|---|---|
| Chiffre d'affaires | 0 | - |
| Bénéfice brut | 0 | 100,00 % |
| Bénéfice net | -2,31 M | 40,78 % |
| EBITDA | -821,01 k | 78,60 % |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 147,93 k € |
Nombre d'actions | 9,34 M |
Plus haut/bas sur 52 semaines | 0,11 € - 0,00861 € |
| Dividendes | Non |
Bêta | -0,50 |
Ratio P/E | -0,07 |
Ratio PEG | 0,00 |
Ratio P/B | -0,06 |
Ratio P/S | 0,00 |
Profil de l'entreprise
| Nom | BIO-PATH HLDGS IN.DL-,001 Aktie |
| PDG | Vikram Paul Grover |
| Employés | 1 |
Découvrir des actifs
Les actionnaires de BIO-PATH HLDGS IN.DL-,001 Aktie investissent également dans les actifs suivants
